Delays getting higher dose Wegovy to patients reported by US doctors

By Maggie Fick, Patrick Wingrove and Elissa Welle

LONDON/NEW YORK, July 14 (Reuters) - Some U.S. patients taking the two highest doses of Novo Nordisk's Wegovy weight-loss drug are facing difficulty filling their prescriptions, eight doctors around the country told Reuters this week, suggesting a new supply challenge for the popular medicine.